Global X Genomics & Biotechnology ETF (GNOM) News Today → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free GNOM Stock Alerts $10.96 +0.15 (+1.39%) (As of 11:44 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 12 at 4:03 AM | americanbankingnews.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest UpdateMay 2, 2024 | investorplace.com3 Gene Editing Stocks with the Potential to Make You an Overnight MillionaireApril 18, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On 10x GenomicsMarch 21, 2024 | investorplace.com3 Stocks That Could Be the Next Big Thing in Gene EditingMarch 14, 2024 | finance.yahoo.comGlobal X Genomics & Biotechnology UCITS ETF (GNOG.L)March 6, 2024 | investing.comGlobal X Genomics & Biotechnology ETF (GNOM)December 29, 2023 | msn.comGlobal X Cannabis ETF declares $0.1656 dividendDecember 14, 2023 | marketbeat.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Expands By 47.6%Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 42,200 shares, an increase of 47.6% from the November 15th total of 28,600 shares. Based on an average daily volume of 285,600 shares, the days-to-cover ratio is presently 0.1 days.August 11, 2023 | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $4.65 Million Stock Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Mirae Asset Global Investments Co. Ltd. lessened its stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Free Report) by 25.3% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 377,749 shares of the company's stock after sellinJuly 17, 2023 | marketbeat.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Rises By 44.8%Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 68,200 shares, an increase of 44.8% from the June 15th total of 47,100 shares. Based on an average daily trading volume, of 71,900 shares, the short-interest ratio is currently 0.9 days.July 12, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Boosts Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Raymond James Financial Services Advisors Inc. grew its stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Free Report) by 32.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 133,829 shares of theJuly 7, 2023 | marketbeat.comJames J. Burns & Company LLC Makes New Investment in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)James J. Burns & Company LLC bought a new stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 12,823 shares of the company's stock, valued aMay 28, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Buys 13,244 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Raymond James Financial Services Advisors Inc. lifted its stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 15.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor oMay 23, 2023 | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $6.40 Million Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Mirae Asset Global Investments Co. Ltd. reduced its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 505,607 shares of theMay 12, 2023 | investing.comGlobal X S&P 500® Catholic Values ETF (CATH)April 29, 2023 | benzinga.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM), Quotes and News SummaryApril 15, 2023 | thestreet.comComplete Genomics Stock Falls On Unusually High Volume (GNOM)April 10, 2023 | marketbeat.com15,239 Shares in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Bought by Clearwater Capital Advisors LLCClearwater Capital Advisors LLC acquired a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 15,239 shares of the company's stocApril 6, 2023 | marketbeat.comSightline Wealth Advisors LLC Grows Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Sightline Wealth Advisors LLC raised its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 34.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,332 shares ofApril 3, 2023 | marketbeat.comPrivate Advisor Group LLC Sells 134,751 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Private Advisor Group LLC lessened its stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 11.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,073,255 shares of the company's stock afteMarch 17, 2023 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Holdings Cut by McGuire Investment Group LLCMcGuire Investment Group LLC decreased its stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 51.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 250,194 shares ofMarch 17, 2023 | marketbeat.comMcGuire Investment Group LLC Sells 266,038 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)McGuire Investment Group LLC lowered its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 51.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 250,194 shares of thMarch 10, 2023 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Significant Decline in Short InterestGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) saw a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 33,200 shares, a decline of 61.4% from the February 13th total of 86,100 shares. Based on an average daily volume of 103,000 shares, the short-interest ratio is presently 0.3 days.March 9, 2023 | marketbeat.comUBS Group AG Sells 24,463 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)UBS Group AG reduced its stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 14.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 139,223 shares of the company's stock after sellMarch 6, 2023 | marketbeat.comMML Investors Services LLC Sells 8,782 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)MML Investors Services LLC reduced its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 14.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 52,942 shares of the company's sFebruary 23, 2023 | marketbeat.comNomura Asset Management Co. Ltd. Acquires 49,700 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Nomura Asset Management Co. Ltd. grew its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 49,700.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 49,800 shares ofFebruary 16, 2023 | benzinga.comGlobal X Adaptive U.S. Risk Management ETF (ONOF): January 2023 ReportFebruary 3, 2023 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Sold by Banco Santander S.A.Banco Santander S.A. cut its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) by 36.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,800 shareJanuary 18, 2023 | seekingalpha.comGNOM: Get Exposure To The Latest Genomics And Biotechnology CompaniesJanuary 10, 2023 | markets.businessinsider.comComplete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023January 6, 2023 | benzinga.comGlobal X Adaptive U.S. Risk Management ETF (ONOF): November ReportDecember 3, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Large Increase in Short InterestGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 47,300 shares, an increase of 48.3% from the October 31st total of 31,900 shares. Based on an average daily trading volume, of 100,400 shares, the days-to-cover ratio is currently 0.5 days.November 11, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 55.8% in OctoberGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) saw a large drop in short interest in October. As of October 31st, there was short interest totalling 31,900 shares, a drop of 55.8% from the October 15th total of 72,100 shares. Based on an average trading volume of 110,400 shares, the days-to-cover ratio is presently 0.3 days.November 4, 2022 | benzinga.comA Preview Of Singular Genomics Systems's EarningsOctober 19, 2022 | seekingalpha.comHow To Invest In Genomics And ImmunologyOctober 13, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 60.7% in SeptemberGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 110,000 shares, a drop of 60.7% from the September 15th total of 279,900 shares. Based on an average daily trading volume, of 108,400 shares, the short-interest ratio is presently 1.0 days.October 12, 2022 | seekingalpha.com10x Genomics: No Signs Of A Growth Turnaround, Heavy Bearish MomentumSeptember 28, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Significant Increase in Short InterestGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 279,900 shares, a growth of 232.0% from the August 31st total of 84,300 shares. Based on an average daily trading volume, of 129,600 shares, the days-to-cover ratio is currently 2.2 days.September 12, 2022 | yahoo.comESMO 2022: REVEAL GENOMICS®️ PRESENTS NEW VALIDATION DATA OF HER2DX®️ IN THE PerELISA TRIALAugust 8, 2022 | benzinga.comGlobal Optical Genome Mapping Market 2022-2027: Featuring Key Players Bionano Genomics, Nabsys, France Genomique & OthersAugust 1, 2022 | marketbeat.comShort Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Declines By 23.2%Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the target of a large decrease in short interest in July. As of July 15th, there was short interest totalling 164,400 shares, a decrease of 23.2% from the June 30th total of 214,100 shares. Based on an average daily volume of 203,400 shares, the days-to-cover ratio is currently 0.8 days.July 15, 2022 | benzinga.comWhat 5 Analyst Ratings Have To Say About 10x GenomicsJuly 2, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Up 56.0% in JuneGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) saw a large growth in short interest in June. As of June 15th, there was short interest totalling 63,500 shares, a growth of 56.0% from the May 31st total of 40,700 shares. Based on an average daily volume of 169,000 shares, the short-interest ratio is currently 0.4 days.June 16, 2022 | benzinga.comNIH's National Human Genome Research Institute and NSTA Unveil New Genome: Unlocking Life's Code Educational Resources for EducatorsJune 6, 2022 | markets.businessinsider.comUltima Genomics Collaborates with NVIDIA To Deliver $100 Genome Sequencing with AI and Accelerated ComputingMay 28, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 44.2% in MayGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the recipient of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 39,600 shares, a drop of 44.2% from the April 30th total of 71,000 shares. Based on an average daily volume of 179,700 shares, the short-interest ratio is presently 0.2 days.January 26, 2022 | finance.yahoo.comSightline Wealth Advisors, LLC Buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF,January 26, 2022 | finance.yahoo.comSightline Wealth Advisors, LLC Buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF, ...January 13, 2022 | finance.yahoo.comMcGuire Investment Group, LLC Buys SPDR Bloomberg 1-3 Month T-Bill ETF, WisdomTree Floating ...January 7, 2022 | marketbeat.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) Sees Large Decrease in Short InterestGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM) was the recipient of a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 69,800 shares, a decline of 30.8% from the November 30th total of 100,800 shares. Based on an average daily volume of 104,100 shares, the short-interest ratio is currently 0.7 days. Get Global X Genomics & Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+. Click here to see why this small company is trusted by the Mayo Clinic GNOM Media Mentions By Week GNOM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNOM News Sentiment▼0.620.96▲Average News Sentiment GNOM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNOM Articles This Week▼30▲GNOM Articles Average Week Get Global X Genomics & Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: WisdomTree Cybersecurity Fund News Today Valkyrie Bitcoin Miners ETF News Today First Trust Indxx Innovative Transaction & Process ETF News Today ERShares Entrepreneurs ETF News Today VanEck Digital Transformation ETF News Today Global X E-Commerce ETF News Today Spear Alpha ETF News Today Global X Video Games & Esports ETF News Today Global X Data Center & Digital Infrastructure ETF News Today Tema Cardiovascular and Metabolics ETF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNOM) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
